Literature DB >> 12361835

Quantitative analysis of human heart valves: does anorexigen exposure produce a distinctive morphological lesion?

Paul C McDonald1, Janet E Wilson, Min Gao, Shannon McNeill, John J Spinelli, O Dale Williams, Salima Harji, Jennifer Kenyon, Bruce M McManus.   

Abstract

The need for more detail regarding the clinical and morphological features of human heart valves has become evident due to recent controversy regarding anorexigen-associated valvular dysfunction. In the present study, we used quantitative digital image analysis of geometric and compositional features to compare the histopathology of cardiac valves excised from patients treated with anorexigens as compared to normal, floppy, rheumatic and carcinoid valves. Anorexigen-exposed valves had the greatest number of onlays/valve (P<.0001), while rheumatic valves showed the greatest average onlay size and thickness of the comparison groups studied (P=.01). The valve onlays from anorexigen-exposed, carcinoid and floppy valves contained a greater percentage of glycosaminoglycans (GAGs) as compared to normal and rheumatic valves (P=.01). The anorexigen-exposed valve propers contained more GAGs than any other comparison group (P=.02). Vessels were prominent in both onlay and valve proper regions of carcinoid valves, in the anorexigen-exposed valve onlays and in rheumatic valve propers. Thus, the number of onlays, their size, the degree of GAG deposition, and the presence and location of vessels and leukocytes were important features distinguishing anorexigen-exposed valves from normal valves. Discriminant analyses, based on geometry, color composition or color composition, and vessel and leukocyte counts combined, were able to separate the valves into distinguishable groups. Our findings demonstrate that specific microscopic features can be used to separate anorexigen-associated heart valve lesions from normal valves and valve lesions associated with other pathologies, and suggest that a distinctive pathological process may exist in many anorexigen-exposed valves.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361835     DOI: 10.1016/s1054-8807(02)00110-2

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  3 in total

1.  Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.

Authors:  Jeanne M Connolly; Marina A Bakay; James T Fulmer; Robert C Gorman; Joseph H Gorman; Mark A Oyama; Robert J Levy
Journal:  Am J Pathol       Date:  2009-08-13       Impact factor: 4.307

2.  Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.

Authors:  Christophe Baufreton; Patrick Bruneval; Marie-Christine Rousselet; Pierre-Vladimir Ennezat; Olivier Fouquet; Raphael Giraud; Carlo Banfi
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

3.  Dexfenfluramine and Pergolide Cause Heart Valve Disease via Valve Metabolic Reprogramming and Ongoing Matrix Remodeling.

Authors:  Cécile Oury; Patrick Maréchal; Nathalie Donis; Alexia Hulin; Alexandre Hego; Julien Tridetti; Mai-Linh Nguyen; Raluca Dulgheru; Marianne Fillet; Alain Nchimi; Patrizio Lancellotti
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.